Weight-loss drugs in spotlight as pharma services firms rush to snap up business https://ift.tt/CA2IGQd

A surge in sales of Novo Nordisk's drug Wegovy, which launched in the United States in mid-2021, has propelled the Danish drugmaker to become Europe's most valuable company.Amid a global obesity crisis, some analysts predict the market for weight-loss drugs could be worth $100 billion by 2030. Some companies, like West Pharmaceutical Services, whose share price is up 37 per cent year to date, are already providing components for the injections pens and reaping rich rewards from the business.

from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/OcauXRQ